AL
Agran Libbie Portfolio holdings
AUM
$425M
This Quarter Return
+2.34%
1 Year Return
+16.08%
3 Year Return
+27.54%
5 Year Return
–
10 Year Return
–
AUM
$413M
AUM Growth
+$413M
(+18%)
Cap. Flow
+$53.3M
Cap. Flow
% of AUM
12.92%
Top 10 Holdings %
Top 10 Hldgs %
29.53%
Holding
128
New
20
Increased
42
Reduced
46
Closed
2
Top Buys
| 1 |
Simon Property Group
SPG
|
$9.37M |
| 2 |
Verizon
VZ
|
$8.64M |
| 3 |
Enterprise Products Partners
EPD
|
$8.38M |
| 4 |
Healthpeak Properties
DOC
|
$7.27M |
| 5 |
OKS
Oneok Partners LP
OKS
|
$6.6M |
Top Sells
| 1 |
Ventas
VTR
|
$5.63M |
| 2 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
$448K |
| 3 |
Teva Pharmaceuticals
TEVA
|
$341K |
| 4 |
Goldman Sachs
GS
|
$257K |
| 5 |
CERN
Cerner Corp
CERN
|
$214K |
Sector Composition
| 1 | Financials | 16.1% |
| 2 | Technology | 15.04% |
| 3 | Energy | 13.7% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares Silver Trust
SLV
$20B
| $393K | 0.1% |
26,013
-1,250
| -5% | -$18.9K |
|
102
Merck
MRK
$213B
| $383K | 0.09% |
6,514
+1,050
| +19% | +$61.7K |
|
103
Middleby
MIDD
$6.91B
| $348K | 0.08% |
2,700
| – | – |
|
104
TC Energy
TRP
$53.5B
| $341K | 0.08% |
+7,550
| New | +$341K |
|
|
TFCFA
105
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $338K | 0.08% |
12,064
-198
| -2% | -$5.55K |
|
106
Johnson Controls International
JCI
$69B
| $330K | 0.08% |
8,022
| – | – |
|
107
Philip Morris
PM
$261B
| $301K | 0.07% |
3,288
| – | – |
|
108
Altria Group
MO
$113B
| $300K | 0.07% |
4,442
| – | – |
|
109
Schlumberger
SLB
$53.5B
| $273K | 0.07% |
3,257
-31
| -0.9% | -$2.6K |
|
110
EOG Resources
EOG
$68.7B
| $266K | 0.06% |
2,635
-650
| -20% | -$65.6K |
|
111
Salesforce
CRM
$240B
| $258K | 0.06% |
3,775
| – | – |
|
112
Norfolk Southern
NSC
$62.1B
| $252K | 0.06% |
2,335
-450
| -16% | -$48.6K |
|
113
General Dynamics
GD
$86.8B
| $233K | 0.06% |
+1,350
| New | +$233K |
|
114
Novo Nordisk
NVO
$249B
| $231K | 0.06% |
6,450
-2,125
| -25% | -$76.1K |
|
115
Novartis
NVS
$244B
| $224K | 0.05% |
3,071
-50
| -2% | -$3.65K |
|
|
DNKN
116
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $222K | 0.05% |
4,235
-8,550
| -67% | -$448K |
|
117
Marvell Technology
MRVL
$54.9B
| $216K | 0.05% |
+15,600
| New | +$216K |
|
118
Ecolab
ECL
$78B
| $212K | 0.05% |
1,807
| – | – |
|
119
Duke Energy
DUK
$94.6B
| $204K | 0.05% |
2,635
+1
| +0% | +$77 |
|
120
Catalyst Pharmaceutical
CPRX
$2.52B
| $46K | 0.01% |
44,000
| – | – |
|
121
Arrowhead Research
ARWR
$3.5B
| $32K | 0.01% |
20,600
+2,210
| +12% | +$3.43K |
|
122
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
| $29K | 0.01% |
+555
| New | +$29K |
|
123
Qualigen Therapeutics
QLGN
$3.03M
| $28K | 0.01% |
10,500
| – | – |
|
124
Energy Select Sector SPDR Fund
XLE
$27.6B
| $23K | 0.01% |
+300
| New | +$23K |
|
125
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $21K | 0.01% |
+300
| New | +$21K |
|